Poverty and corruption affecting antimicrobial resistance: a silent pandemic

Santosh Kumar Swain; Pragnya Paramita Jena

doi:10.18203/2320-6012.ijrms20264221

Authors

Santosh Kumar Swain Department of Microbiology, IMS and SUM Hospital, Siksha “O” Anusandhan University, Bhubaneswar, Odisha, India
Pragnya Paramita Jena Department of Microbiology, IMS and SUM Hospital, Siksha “O” Anusandhan University, Bhubaneswar, Odisha, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20264221

Keywords:

Antimicrobial resistance, Micro-organism, Poverty, Corruption, Developing countries

Abstract

Antimicrobial resistance (AMR) occurs when microorganisms like bacteria, viruses, fungi, and parasites become able to adapt and grow even with medications that once killed them. AMR is a growing global problem. The causes for AMR in countries with poverty and corruption are complex and may be rooted in the practices of health care professionals and behaviour of patients towards the use of antimicrobials as well as supply chains of antimicrobials in the public. The factors like inappropriate prescription practices, insufficient patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, absence of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as animal production. This can lead to serious infections and cause difficulty in treatment of the infections. Poverty and corruption are two important parameters which strongly accelerate AMR by weakening drug regulation and forcing reliance on cheap or fake medicine. Poor infection control, poor water sanitation and poor hygiene all increase the spread of resistant bacteria from person to person. The appropriate use of antibiotic is related to economic development of countries. According to the World Health Organization (WHO), poverty is very crucial for development of AMR. This review discusses the importance of governmental, social, and economic factors related to antibiotic resistance including poverty and corruption.

References

Larsson DJ, Flach CF. Antibiotic resistance in the environment. Nat Rev Microbiol. 2022;20:257-69.

Ikhimiukor OO, Odih EE, Donado-Godoy P, Okeke IN. A bottom-up view of antimicrobial resistance transmission in developing countries. Nature Microbiol. 2022;7(6):757-65.

Hou J, Long X, Wang X, Li L, Mao D, Luo Y, Ren H. Global trend of antimicrobial resistance in common bacterial pathogens in response to antibiotic consumption. J Hazardous Materials. 2023;442:130042.

Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One.2017;12:0189621.

Vikesland P, Garner E, Gupta S, Kang S, Maile-Moskowitz A, Zhu NI. Differential drivers of antimicrobial resistance across the world. Accounts Chemical Res. 2019;52(4):916-24.

Collignon P, Beggs JJ. Socioeconomic enablers for contagion: factors impelling the antimicrobial resistance epidemic. Antibiotics. 2019;8:86.

Swain SK. Management of acute invasive fungal sinusitis. Mustansiriya Med J. 2022;21(2):104-10.

Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199-226.

Vikesland P, Garner E, Gupta S, Kang S, Maile-Moskowitz A, Zhu NI. Differential drivers of antimicrobial resistance across the world. Accounts Chemical Res. 2019;52(4):916-24.

Hanh NT, Tram PT, Ha HT, Duc BH, Huong PT, Quoc NC, et al. Detection of antiretroviral drug-resistant mutations and HIV-1 subtypes in circulation among men who have sex with men, SEM females and female sex workers: results of Vietnam’s HIV Sentinel Surveillance Plus (HSS+) system, 2018–2020. J Acquired Immune Deficiency Syndromes (1999). 2025;98(1):29.

Lindman J, Djalo MA, Biai A, Månsson F, Esbjörnsson J, Jansson M, et al. The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau. AIDS Res Therapy. 2020;17(1):33.

Swain SK, Jena PP. Microbiome of the head-and-neck region. Mustansiriya Medical J. 2022;21(1):8-12.

Mamun KZ. Prevalence and genetics of resistance to commonly used antimicrobial agents in faecal enterobacteriaceae from children in Bangladesh (thesis). University of Liverpool. 1991.

Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial Resistance Infect Control. 2017;6(1):47.

Rönnerstrand B, Lapuente V. Corruption and use of antibiotics in regions of Europe. Health Policy. 2017;121(3):250-6.

Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999;5:18-27.

Lansang MA, Lucas-Aquino R, Tupasi TE, Mina VS, Salazar LS, Juban N, et al. Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses. J Clin Epidemiol. 1990;43(1):61-7.

World Health Organization. Overcoming antimicrobial resistance. World Health Organization report on infectious diseases. World Health Organization. 2000. Available at: https:// wellcomecollection.org/works/hucutve9. Accessed on 17 August 2026.

Naher N, Hoque R, Hassan MS, Balabanova D, Adams AM, Ahmed SM. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia. BMC Public Health. 2020;20(1):880.

Bukari C, Seth S, Yalonetkzy G. Corruption can cause healthcare deprivation: evidence from 29 sub-Saharan African countries. World Dev. 2024;180:106630.

Collignon P, Athukorala PC, Senanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PloS one. 2015;10(3):e0116746.

Ahmed SA, Barış E, Go DS, Lofgren H, Osorio-Rodarte I, Thierfelder K. Assessing the global poverty effects of antimicrobial resistance. World Development. 2018;111:148-60.

Alvarez-Uria G, Gandra S, Laxminarayan R. Poverty and prevalence of antimicrobial resistance in invasive isolates. Int J Infect Dis. 2016;52:59-61.

Lenka S, Dubey D, Rath S, Das S, Swain SK. Clinical manifestation and microbial profiling of recurrent MDR microorganisms associated with head and neck infection-a retrospective study. Healthcare Low-Resource. 2023;11:11527.

Rönnerstrand B, Lapuente V. Corruption and use of antibiotics in regions of Europe. Health Policy. 2017;121(3):250-6.

Swain SK. Actinomycosis in head-and-neck region–A review. Matrix Science Medica. 2022;6(1):1-5.

Usluer G, Ozgunes I, Leblebicioglu H, Turkish antibiotic utilization study group. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.

Saleh N, Awada S, Awwad R, Jibai S, Arfoul C, Zaiter L, et al. Evaluation of antibiotic prescription in the Lebanese community: a pilot study. Infect Ecol Epidemiol. 2015;5:27094.

Sharma A, Singh A, Dar MA, Kaur RJ, Charan J, Iskandar K, et al. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. Journal of Infection and Public Health. 2022;15(2):172-81.

Lansang MA, Lucas-Aquino R, Tupasi TE, Mina VS, Salazar LS, Juban N, et al. Purchase of antibiotics without prescription in Manalia, the Philippines. Inappropriate choices and doses. J Clin Epidemiol. 1990;43:61-7.

Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis. 2007;13:1640-6.

Goel P, Ross-Degnan D, Berman P, Soumerai S. Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med. 1996;42:1155-61.

Kwena Z, Sharma A, Wamae N, Muga C, Bukusi E. Provider characteristics among staff providing care to sexually transmitted infection self-medicating patients in retail pharmacies in Kibera slum, Nairobi. Kenya Sex Transm Dis. 2008;35:480-3.

Swain SK, Debta P, Sahu A, Lenka S. Oral cavity manifestations by COVID-19 infections: a review. Int J Otorhinolaryngol Head Neck Surg. 2021;7(8):1391-7.

Smith MA, Garbharran H, Edwards MJ, O’Hara-Murdock P. Health promotion and disease prevention through sanitation education in south African Zulu and Xhosa women. J Transcult Nurs Off J Transcult Nurs Soc. 2004;15:62-8.

Swain SK, Kumar S. Infection control measures during COVID-19 pandemic–An otorhinolaryngological and head-and-neck perspective. Indian J Health Sci Biomed Res. 2021;14(1):3-11.

Swain SK, Sahana R. Deep neck space infection in the paediatric age group–A review. Pediat Polska-Polish J Paediat. 2020;95(3):169-74.

Gandra S, Alvarez-Uria G, Turner P, Joshi J, Limmathurotsakul D, van Doorn HR. Antimicrobial resistance surveillance in low-and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries. Clin Microbiol Rev. 2020;33(3):10-128.

Swain SK, Singh V. Melioidosis in the head-and-neck region. J Clin Scientific Res. 2024;13(3):223-7.